acetylgalactosamine has been researched along with 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Buchegger, F; Chyan, MK; Hamlin, DK; Lin, Y; Pagel, JM; Pantelias, A; Park, SI; Press, OW; Shenoi, J; Wan, F; Wilbur, DS; Wilbur, SM | 1 |
Axworthy, DB; Cheal, SM; Cheung, NV; Guo, HF; Larson, SM; Ouerfelli, O; Patel, M; Veach, D; Xu, H; Yang, G; Zanzonico, PB | 1 |
2 other study(ies) available for acetylgalactosamine and 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
Article | Year |
---|---|
Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutants.
Topics: Acetylgalactosamine; Animals; Antigens, CD20; Biotin; Cell Line, Tumor; Chelating Agents; Drug Design; Heterocyclic Compounds, 1-Ring; Humans; Lymphoma, B-Cell; Mice; Molecular Structure; Mutation; Recombinant Fusion Proteins; Single-Chain Antibodies; Streptavidin; Xenograft Model Antitumor Assays | 2010 |
An
Topics: Acetylgalactosamine; Animals; Biotin; Cell Line, Tumor; Colorectal Neoplasms; Dendrimers; Haptens; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Mice; Radioimmunotherapy; Tissue Distribution; Xenograft Model Antitumor Assays | 2020 |